X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
iran (7) 7
humans (6) 6
kenya (6) 6
pharmacology & pharmacy (6) 6
systematic review (6) 6
analysis (5) 5
meta-analysis (5) 5
adherence (4) 4
drug utilization (4) 4
expenditure (4) 4
health care sciences & services (4) 4
initiatives (4) 4
prevalence (4) 4
antibiotics (3) 3
antimicrobial resistance (3) 3
care (3) 3
chemotherapy (3) 3
consumption (3) 3
depression (3) 3
female (3) 3
health policy (3) 3
hemodialysis (3) 3
medicine, general & internal (3) 3
medicines (3) 3
mental depression (3) 3
original research (3) 3
patients (3) 3
pharmacology (3) 3
quality of life (3) 3
reforms (3) 3
risk (3) 3
scottish nhs (3) 3
studies (3) 3
abridged index medicus (2) 2
antibiotic consumption (2) 2
antibiotic resistance (2) 2
antibiotic utilization (2) 2
antimicrobial resistance surveillance (2) 2
asthma (2) 2
brazil (2) 2
burden (2) 2
cancer (2) 2
case-history (2) 2
clinical practice research datalink (2) 2
demand-side measures (2) 2
developing countries (2) 2
diabetes (2) 2
drug resistance (2) 2
drug resistance in microorganisms (2) 2
drugs (2) 2
efficacy (2) 2
efficiency (2) 2
enhance (2) 2
enhance prescribing efficiency (2) 2
europe (2) 2
european surveillance (2) 2
european union (2) 2
forecasts and trends (2) 2
generics (2) 2
health aspects (2) 2
hiv (2) 2
hospitals (2) 2
hypertension - epidemiology (2) 2
impact (2) 2
iran - epidemiology (2) 2
knowledge (2) 2
male (2) 2
management (2) 2
medical care (2) 2
medication adherence (2) 2
midwifery (2) 2
multiple initiatives (2) 2
oncology (2) 2
original (2) 2
peripheral vascular disease (2) 2
persistence (2) 2
pharmaceutical industry (2) 2
poland (2) 2
public health (2) 2
public, environmental & occupational health (2) 2
quality indicators (2) 2
research (2) 2
resistance (2) 2
respiratory-tract infections (2) 2
risk factors (2) 2
therapy (2) 2
utilization (2) 2
1st-line treatment (1) 1
2nd-generation antipsychotics (1) 1
2nd-line antiretroviral therapy (1) 1
5-fluorouracil (1) 1
abc (1) 1
abc analysis (1) 1
acids (1) 1
adequacy of dialysis (1) 1
adverse drug-reactions (1) 1
africa (1) 1
ambulatory care (1) 1
ambulatory medical care (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medical research and opinion, 08/2018, p. 1
There is a paucity of antipsychotic prescribing and utilization data in Pakistan that needs addressing, especially with issues of availability, affordability,... 
Journal Article
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, ISSN 1871-4021, 01/2019, Volume 13, Issue 1, pp. 402 - 407
Diabetes is the most common metabolic causes of increased mortality rate due to its multiple complications. Diabetes, thus, influences patients’ quality of... 
Health-related quality of life | Diabetes | Iran | Meta-analysis | Quality of Life | Iran - epidemiology | Humans | Diabetes Mellitus, Type 2 - therapy | Diabetes Mellitus, Type 2 - epidemiology | Psychological aspects | Diabetics | Patient outcomes | Analysis | Health aspects | Quality of life
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 2018, Volume 14, pp. 3073 - 3080
Journal Article
Journal of Hypertension, ISSN 0263-6352, 06/2019, Volume 37, Issue 6, pp. 1285 - 1293
OBJECTIVE:To evaluate the clinical and cost impact of switching angiotensin receptor blockers (ARBs) to angiotensin-converting enzyme inhibitors (ACEIs) in... 
SUBSTITUTION | cost-saving strategies | MYOCARDIAL-INFARCTION | PERSISTENCE | angiotensin-converting enzyme inhibitors/angiotensin receptor blockers | RISK | ADHERENCE | CARE | IMPACT | COST | Clinical Practice Research Datalink | PERIPHERAL VASCULAR DISEASE | hypertension | therapeutic switching
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 01/2018, Volume 16, Issue 1, pp. 77 - 84
Background: There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among... 
Azerbaijan | policy initiatives | quality indicators | antibiotic resistance | Antibiotic utilization | QUALITY | CASE-HISTORY | EUROPE | MULTIPLE INITIATIVES | PRIMARY-CARE | ENHANCE | RESISTANCE | PHARMACOLOGY & PHARMACY | BURDEN | PRESCRIBING EFFICIENCY | CONSUMPTION
Journal Article
Expert review of anti-infective therapy, 12/2017
There have been a numerous initiatives in Azerbiajan in recent years to improve antibiotic utilization including educational programmes among patients,... 
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 05/2019, Volume 19, Issue 5, pp. 423 - 430
Journal Article
Journal of Research in Pharmacy Practice, ISSN 2319-9644, 01/2019, Volume 8, Issue 3, pp. 149 - 154
Objective: Antibiotics are essential with inappropriate use leading to antimicrobial resistance (AMR). Currently, little is known about antibiotic use among... 
point prevalence survey | prescribing | utilization | Antibiotics | Kenya
Journal Article
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 12/2018, Volume 9, p. 1348
Background: Medicines can constitute up to 70% of total health care budgets in developing countries as well as considerable expenditure in hospitals. Inventory... 
expenditure | hospitals | SOUTH-AFRICA | ABC | PHARMACY | medicines | Kenya | ADVERSE DRUG-REACTIONS | VEN analysis | VED ANALYSIS | OPTIMIZE | MODELS | RECOMMENDATIONS | STORE | PHARMACOLOGY & PHARMACY | ABC analysis | Drugs | Inventory control | Consumption (Economics) | Consumption data | Medical care, Cost of | Economic aspects | Medical care | Forecasts and trends | Utilization | Customer relations | Pharmaceutical industry
Journal Article
Journal of hypertension, 12/2018
To evaluate the clinical and cost impact of switching angiotensin receptor blockers (ARBs) to angiotensin-converting enzyme inhibitors (ACEIs) in patients with... 
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 09/2019, p. 107815521986943
Introduction The chemotherapy use process is potentially risky for cancer patients. Vincristine, a “High Alert” medicine, has been associated with fatal but... 
Journal Article
BioDrugs, ISSN 1173-8804, 2018, Volume 32, Issue 6, pp. 585 - 606
BackgroundThe last decade has seen the increasing use of biological medicines in combination with chemotherapy containing 5-fluorouracil/oxaliplatin or... 
UNITED-STATES | 1ST-LINE TREATMENT | COST-EFFECTIVENESS | PLUS IRINOTECAN | EFFICACY | OXALIPLATIN | IMMUNOLOGY | ONCOLOGY | CLINICAL BENEFIT | ANALOG GLARGINE | PHARMACOLOGY & PHARMACY | INSULIN GLARGINE | DISEASE PROGRESSION | Panitumumab - economics | Bevacizumab - therapeutic use | Intestinal Perforation - epidemiology | Oxaliplatin - economics | Humans | Fluorouracil - economics | Oxaliplatin - therapeutic use | Response Evaluation Criteria in Solid Tumors | Cetuximab - therapeutic use | Intestinal Perforation - chemically induced | Irinotecan - therapeutic use | Incidence | Fluorouracil - therapeutic use | Colorectal Neoplasms - drug therapy | Hypertension - chemically induced | Antineoplastic Combined Chemotherapy Protocols - economics | Brazil | Panitumumab - therapeutic use | Hypertension - epidemiology | Bevacizumab - economics | Colorectal Neoplasms - mortality | Irinotecan - economics | Disease-Free Survival | Cetuximab - economics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Reimbursement Mechanisms - legislation & jurisprudence | Fees, Pharmaceutical | 5-Fluorouracil | Colorectal carcinoma | Colorectal cancer | Systematic review | Metastasis | Drug resistance | Cancer therapies | Bevacizumab | Metastases | Oxaliplatin | Safety | Pharmaceutical industry | Growth factors | Immunoglobulins | Statistical analysis | Survival | Disease control | Patients | Meta-analysis | Studies | Irinotecan | Chemotherapy | Acids | Monoclonal antibodies | Internet | Solid tumors | Index Medicus
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2019, Volume 35, Issue S1, pp. 96 - 96
IntroductionThe growing prevalence of non-communicable diseases, combined with greater recognition of the effectiveness of lipid lowering agents (LLAs), has... 
Journal Article
CLINICS, ISSN 1807-5932, 2019, Volume 74, p. e950
OBJECTIVES: Evaluate the use of probiotics as an additional therapy in the treatment of children and adolescents with asthma in Belo Horizonte, MG-Brazil.... 
Probiotics | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | Public Health | Brazil | Respiratory Function Tests | Respiratory Hypersensitivity | LACTOBACILLUS | CONSUMPTION | Asthma | CHILDREN | MILK | Original
Journal Article
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, ISSN 1871-4021, 05/2019, Volume 13, Issue 3, pp. 1911 - 1915
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 05/2019, Volume 19, Issue 5, pp. 423 - 430
Background: Chemotherapy-related side effects and their management in patients with Non-Hodgkin's Lymphoma (NHL) are not well defined in developing countries,... 
side effects | Chemotherapy | Non-Hodgkin Lymphoma | Kenya | developing countries | BURKITT-LYMPHOMA | HIV | ONCOLOGY | CHILDHOOD | TRENDS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.